Cybereason, a leading global cybersecurity company, today announced the launch of a new Vulnerability Management product, a ...

As the Hong Kong daily "HongKong Telegraph" recently learned, the SCANDIC TRUST GROUP, an internationally operating ...

Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 -- Reported highly ...

Collaboration to enable payouts to stablecoin wallets, giving banks, payment providers, and end-users greater choice and flexibility SINGAPORE, Nov. 13, 2025 /PRNewswire/ ...

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 - WALTHAM, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Zenas BioP ...

- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of ...

Arctic Wolf ®, a global leader in security operations, today announced plans to enhance Aurora™ Endpoint Security with upcoming AI-powered ransomware prevention and rollback capabilities. Through the ...

Bitdefender, a global cybersecurity leader, today announced the worldwide availability of GravityZone Proactive Hardening and Attack Surface Reduction (PHASR) as a standalone solution, making its ...

IGEL, is a global leader in secure endpoint delivery, adaptive secure desktop solutions, and the IGEL Secure Endpoint OS Platform for now and next. It enables hybrid work, accelerates cloud adoption, ...

An AWS, Amazon Web Services, logo is displayed at LlamaCon 2025, an AI developer conference, in Menlo Park, Calif., Tuesday, April 29, 2025. Jeff Chiu / AP Internet disruptions tied to Amazon’s cloud ...

The consumer protection service announced on Friday that it has received complaints from customers about two websites and their associated social media pages allegedly selling counterfeit products.